Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Management of Acute on Chronic Radicular Pain from L5 Nerve Root Compression

Current Medication Analysis

  • The American College of Physicians suggests that paracetamol has limited evidence for efficacy in radicular pain 1
  • The Mayo Clinic recommends pregabalin for neuropathic pain component 2
  • The Mayo Clinic suggests that venlafaxine, an SSNRI, has some efficacy in neuropathic pain 2
  • The American College of Physicians states that buprenorphine patch, an opioid, has a modest effect on chronic low back pain 1

First-line Options to Consider

  • The American College of Physicians recommends NSAIDs as first-line treatment for acute radicular pain due to their moderate efficacy and better safety profile compared to other options 3
  • The American College of Physicians suggests that for radicular low back pain, evidence for NSAIDs is limited but they represent a reasonable option with fewer adverse effects than continuing to escalate opioid therapy 1, 4

Second-line Options

  • The American College of Physicians recommends duloxetine as it has shown small improvements in pain intensity and function in chronic low back pain compared to placebo (moderate-quality evidence) 1, 5

Medications to Avoid

  • The American College of Physicians advises that benzodiazepines should be avoided as low-quality evidence showed diazepam resulted in a lower likelihood of pain improvement at 1 week compared with placebo in radicular pain 4, 6
  • The American College of Physicians states that systemic corticosteroids show no significant difference in pain compared to placebo for radicular low back pain (moderate-quality evidence) 4, 6

Treatment Algorithm

  • The American College of Physicians suggests adding an NSAID (preferably COX-2 selective to reduce GI side effects) 1, 3
  • The Mayo Clinic recommends monitoring for GI, renal, and cardiovascular adverse effects 2
  • The American College of Physicians advises considering switching venlafaxine to duloxetine (60mg daily) which has better evidence for pain relief in this context 5, 8

Cautions and Considerations

  • The American College of Physicians warns that the patient is already on multiple centrally-acting medications, increasing the risk of CNS side effects including sedation 1, 6
  • The American College of Physicians states that adding more opioids is unlikely to provide significant additional benefit as moderate-quality evidence shows no differences among different long-acting opioids for pain or function 1, 9
  • The American College of Physicians notes that lumbar radiculopathy appears relatively refractory to many first and second-line medications, including opioids 3
  • The American College of Physicians advises that polypharmacy increases risk of adverse events and drug interactions, so careful monitoring is essential 6

Monitoring Recommendations

  • The Mayo Clinic recommends assessing pain relief and functional improvement after 1-2 weeks of therapy 2
  • The American College of Physicians suggests monitoring for adverse effects, particularly sedation, dizziness, and constipation 6
  • The Mayo Clinic advises considering tapering medications that show limited benefit to reduce polypharmacy 2